- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Alzheimer’s disease and immunotherapy ; volume:3 ; number:1 ; day:23 ; month:8 ; year:2024 ; pages:1-16 ; date:12.2024
Current medicine ; 3, Heft 1 (23.8.2024), 1-16, 12.2024
- Creator
-
Qin, Wei
Pang, Yana
Nie, Shuya
Quan, Meina
Jia, Jianping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s44194-024-00035-8
- URN
-
urn:nbn:de:101:1-2411120851356.944536013884
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Qin, Wei
- Pang, Yana
- Nie, Shuya
- Quan, Meina
- Jia, Jianping
- SpringerLink (Online service)
Other Objects (12)
Immunotherapy for Alzheimer’s disease: hoops and hurdles
Active immunotherapy options for Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Passive immunotherapy for Alzheimer’s disease: challenges & future directions
Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
Alzheimer’s Disease
Endocytosis and Alzheimer’s disease
Alzheimer’s disease and gut microbiota
Immunosenescence, inflammation and Alzheimer’s disease
Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
Cerebrovascular disease in ageing and Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: hoops and hurdles
Active immunotherapy options for Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Passive immunotherapy for Alzheimer’s disease: challenges & future directions
Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
Alzheimer’s Disease
Endocytosis and Alzheimer’s disease
Alzheimer’s disease and gut microbiota
Immunosenescence, inflammation and Alzheimer’s disease
Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
Cerebrovascular disease in ageing and Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: hoops and hurdles
Active immunotherapy options for Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Passive immunotherapy for Alzheimer’s disease: challenges & future directions
Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
Alzheimer’s Disease
Endocytosis and Alzheimer’s disease
Alzheimer’s disease and gut microbiota
Immunosenescence, inflammation and Alzheimer’s disease
Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model